Biliary stone disease affects over 16 million people in the United States. Approximately 1 million new cases of cholelthiasis develop each year and surgical intervention was required in 554,000 procedures in 1984, a 3% increase from 1983. The average length of hospitalization for these patients is between 9 and 16 days. Candela proposes to develop a laser technique for fragmentation of biliary stones to facilitate endoscopic removal. The objective of the study will be to identify optimum operating parameters to permit selective absorption of laser wavelength by biliary stones with minimal absorption by the common duct. Specific objectives of the study are 1) determine the optimum laser parameters - wavelength, pulse energy, pulsewidth, and pulse repetition frequency, 2) develop a solid state or dye laser with the appropriate output characteristics, and 3) establish the safety and efficacy of the treatment technique in animal studies. The research offers the potential to establish operating criteria for a minimally invasive system to remove common duct stones. The technology could potentially be extended to a percutaneous technique to treat stones in the gall bladder. If successful, clinical trials will follow and Candela will pursue design, development, and commercialization of a clinical system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK037754-01
Application #
3495587
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1986-09-22
Project End
1987-02-21
Budget Start
1986-09-22
Budget End
1987-02-21
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Candela Corporation
Department
Type
DUNS #
City
Wayland
State
MA
Country
United States
Zip Code
01778